Literature DB >> 9723384

Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients.

Z Varghese1, R L Fernando, G Turakhia, E Psimenou, C Brunton, O N Fernando, A Davenport, A Burns, P Sweny, S H Powis, J F Moorhead.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9723384     DOI： 10.1016/s0041-1345(98)00532-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 3.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Oxidative stress and antioxidant defense systems in patients after heart transplantation.

Authors:  Ivan Pechan; Katarina Danova; Ingrid Olejarova; Lukac Halcak; Viera Rendekova; Juraj Fabian
Journal:  Wien Klin Wochenschr       Date:  2003-09-30       Impact factor: 1.704
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.